Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation.
D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000378:metabolism; D001095:Arachidonic Acids / Q000494:pharmacology; D001241:Aspirin / Q000037:antagonists & inhibitors*; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors; D011464:Epoprostenol / Q000096:biosynthesis*; D066298:In Vitro Techniques; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000096:biosynthesis*; D051381:Rats; D012980:Sodium Salicylate / Q000494:pharmacology*
D001095:Arachidonic Acids; D016861:Cyclooxygenase Inhibitors; D011453:Prostaglandins; D008315:Malondialdehyde; D011464:Epoprostenol; D001241:Aspirin; D012980:Sodium Salicylate